Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer

(2015) Hui Zhou et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway

(2015) Dingqi Sun et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells

(2015) Ye Lei et al.   PLoS One

Systems biology of cisplatin resistance: past, present and future

(2014) L Galluzzi et al.   Cell Death & Disease

5-Aza-2′-Deoxycytidine Enhances Maspin Expression and Inhibits Proliferation, Migration, and Invasion of the Bladder Cancer T24 Cell Line

(2013) Huihui Zhang et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

(2013) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Maspin influences response to doxorubicin by changing the tumor microenvironment organization

(2013) Tiziana Triulzi et al.   INTERNATIONAL JOURNAL OF CANCER

Maspin: molecular mechanisms and therapeutic implications

(2012) Thomas M. Bodenstine et al.   CANCER AND METASTASIS REVIEWS

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer

(2011) Iver Nordentoft et al.   BMC CANCER

Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder

(2011) Chih-Hao Sun et al.   HISTOPATHOLOGY

Update on Chemotherapy in the Treatment of Urothelial Carcinoma

(2011) Carrie Costantini et al.   TheScientificWorldJOURNAL

Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells

(2011) Deyao Wu et al.   UROLOGIA INTERNATIONALIS

Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas

(2010) Nozomu Tanji et al.   International Journal of Clinical Oncology

The Tumor Suppressor Maspin Mediates E2F1-Induced Sensitivity of Cancer Cells to Chemotherapy

(2010) B. Ben Shachar et al.   MOLECULAR CANCER RESEARCH

Advanced bladder cancer: Status of first-line chemotherapy and the search for active agents in the second-line setting

(2008) David J. Gallagher et al.   CANCER

Curcumin and cancer: An “old-age” disease with an “age-old” solution

(2008) Preetha Anand et al.   CANCER LETTERS